HemaTerra Technologies Receives Investment from The Riverside Company

HemaTerra, a software provider to blood and plasma collection centers and hospitals, is pleased to announce an investment by The Riverside Company, a global private equity firm. The infusion of growth capital will enable HemaTerra to broaden its product line and add resources to help organizations manage their complex supply chains.

“We chose to partner with Riverside because they share our view of the importance of providing top-notch software products and service to the blood, plasma, and hospital industry,” said HemaTerra CEO Todd Collins. “Together we will be able to enhance our leadership position and continue exceeding what our customers have come to expect from us.”

“We couldn’t be more excited to work with HemaTerra’s management team to continue the momentum they are experiencing,” said Riverside Vice President Garrett Monda. “From day one, we were impressed by HemaTerra’s ability to help its customers navigate the complex and mission-critical challenges they face every day.”

The partnership with Riverside will allow HemaTerra to build on its industry-leading product offerings by investing in new product development, enhancing sales and marketing, and pursuing strategic partnerships and combinations.

About HemaTerra Technologies
HemaTerra provides industry-leading software that integrates to provide blood, plasma, and hospital organizations with a broad view of their supply chain for complete operations management. The suite of products assists customers with hospital order entry, donor recruitment, mobile drives, collections staffing, product QC, and equipment maintenance. Integration removes the barriers of information across departments so that customers can seamlessly run their entire operations.

About The Riverside Company
The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 600 investments. The firm’s international private equity and structured capital portfolios include more than 90 companies.